URAT 1 inhibition by ALPK 1 is associated with uric acid homeostasis ALPK 1 and SLC 22 A 12 in uric acid homeostasis

Objective. The aim of this study was to identify a protein for urate transporter 1 (URAT1) regulation. Methods. The clinical dataset consisted of 492 case control samples of Han Chinese (104 gout and 388 controls). Three alpha kinase 1 (ALPK1) and SLC22A12 loci associated with high gout risk and uric acid levels were genotyped. The overexpression of ALPK1 on URAT1 protein expression was evaluated in vivo in hALPK1 transgenic mice. The in vitro protein levels of ALPK1 and URAT1 in ALPK1 small interfering RNA transfected human kidney-2 cells with MSU crystal stimulation were examined. Results. ALPK1, which is a single nucleotide polymorphism (SNP) of rs11726117 (M861T; T), reduced the risk of gout via the SLC22A12 gene SNPs rs3825016 and rs475688, as compared with the subject of ALPK1 rs11726117 (C) allele {rs11726117 [CT + TT] vs rs3825016, odds ratio [OR] 0.39 [95% confidence interval (CI) 0.23, 0.67]; rs11726117 [CT + TT] vs rs475688, OR 0.39 [95% CI 0.23, 0.67]}. ALPK1-overexpressed mice demonstrated lower levels of URAT1 protein (P = 0.0045). Mouse endogenous ALPK1 proteins were detected in renal proximal tubule cells. MSU crystals inhibited URAT1 expressions through an upregulation of ALPK1 in human kidney-2 cells. Conclusion. Elevated ALPK1 expression decreased URAT1 expression. ALPK1 might prevent the impact of urate reuptake via SLC22A12 and appeared to be negatively associated with gout. ALPK1 is a potential repressor of URAT1 protein expression.

[1]  Y. Ko,et al.  ALPK1 phosphorylates myosin IIA modulating TNF-α trafficking in gout flares , 2016, Scientific Reports.

[2]  N. Shinomiya,et al.  The effects of URAT1/SLC22A12 nonfunctional variants,R90H and W258X, on serum uric acid levels and gout/hyperuricemia progression , 2016, Scientific Reports.

[3]  Y. Ko,et al.  ALPK1 affects testosterone mediated regulation of proinflammatory cytokines production , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[4]  J. Štekrová,et al.  Hereditary Renal Hypouricemia Type 1 and Autosomal Dominant Polycystic Kidney Disease , 2015, The American journal of the medical sciences.

[5]  J. Bernasovská,et al.  High frequency of SLC22A12 variants causing renal hypouricemia 1 in the Czech and Slovak Roma population; simple and rapid detection method by allele-specific polymerase chain reaction , 2015, Urolithiasis.

[6]  H. Xie,et al.  Uric acid crystal could inhibit Numb-induced URAT1 lysosome degradation in uric acid nephropathy , 2015, Journal of Physiology and Biochemistry.

[7]  K. Wakai,et al.  Common variant of ALPK1 is not associated with gout: a replication study , 2014, Human Cell.

[8]  K. Pavelka,et al.  Complex Analysis of Urate Transporters SLC2A9, SLC22A12 and Functional Characterization of Non-Synonymous Allelic Variants of GLUT9 in the Czech Population: No Evidence of Effect on Hyperuricemia and Gout , 2014, PloS one.

[9]  Shih-Feng Tsai,et al.  ALPK1 genetic regulation and risk in relation to gout. , 2013, International journal of epidemiology.

[10]  K. Satoh,et al.  Identification of chromosome 3q28 and ALPK1 as susceptibility loci for chronic kidney disease in Japanese individuals by a genome-wide association study , 2013, Journal of Medical Genetics.

[11]  Y. Ko,et al.  Lymphocyte α-kinase is a gout-susceptible gene involved in monosodium urate monohydrate-induced inflammatory responses , 2011, Journal of Molecular Medicine.

[12]  H. Saito,et al.  The Effect of Testosterone Upon the Urate Reabsorptive Transport System in Mouse Kidney , 2010, Nucleosides, nucleotides & nucleic acids.

[13]  Dongmei Meng,et al.  Multiple single nucleotide polymorphisms in the human urate transporter 1 (hURAT1) gene are associated with hyperuricaemia in Han Chinese , 2009, Journal of Medical Genetics.

[14]  Y. Ko,et al.  The SLC22A12 gene is associated with gout in Han Chinese and Solomon Islanders , 2009, Annals of the rheumatic diseases.

[15]  A. Ryazanov,et al.  α-Kinase 1, a New Component in Apical Protein Transport* , 2005, Journal of Biological Chemistry.

[16]  M. Hediger,et al.  Molecular physiology of urate transport. , 2005, Physiology.

[17]  M. Mihatsch,et al.  Uric acid nephropathy and end-stage renal disease--review of a non-disease. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  G. Burckhardt,et al.  URAT1 mutations cause renal hypouricaemia type 1 in Iraqi Jews , 2011 .

[19]  R. Terkeltaub.  Update on gout: new therapeutic strategies and options , 2010, Nature Reviews Rheumatology.

[20]  J. Graessler,et al.  Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. , 2006, Arthritis and rheumatism.